2025³â 08¿ù 05ÀÏ È­¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92443°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

¡®¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©¡¯ °³ÃÖ

»ó¼³ üÇèºÎÅÍ »ê»ç Äܼ­Æ®, ¸í»çÃÊû¹ýȸ±îÁö¡¦ ½ÅÁß³âÃþ ¸ÂÃã ÇÁ·Î±×·¥
º¸ÇöÇà¿øÀ» ½ÇõÇÏ´Â Àü¹ýµµ·® ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç(ÁÖÁö °¡¼·½º´Ô)°¡ 8¿ù 1ÀϺÎÅÍ 10¿ù 31ÀϱîÁö 3°³¿ù°£ ¹®ÇÐÀ» ÅëÇÑ ¸¶À½ Ä¡À¯ ÇÁ·Î±×·¥ ‘Á¦3ȸ ¹®ÇÐÀ¸·Î ¸¸µå´Â ¸¶À½ÀÇ Æò¾È, ±Ý°­À§Å©(ÁÖÃÖ ¹× ÁÖ°ü: ´ëÇѺұ³Á¶°èÁ¾ ±Ý°­Á¤»ç, ÈÄ¿ø: °æ±âµµ)’¸¦ ÁøÇàÇÑ´Ù°í 30ÀÏ ¹àÇû´Ù. °æ±âµµ ±¤¸í½Ã¿¡ À§Ä¡ÇÑ ±Ý°­Á¤»ç´Â ȸÁÖ½º´ÔÀ̽Šº®¾Ï(ÁöÈ«)½º´Ô°ú Àç°¡ºÒÀÚµéÀÇ ¿ø·ÂÀ¸·Î ºÒ±â 2535³â(1991³â) 1¿ù °³¿øÇÑ ½ÅÇà °øµ¿Ã¼´Ù. È£¹ý¹ýȸ ¹× ÀÏ¿ä¹ýȸ µî ´Ù¾çÇÑ Á¤±â¹ýȸ¸¦ ºñ·ÔÇØ ‘³» ¸¶À½ÀÇ Çູ¿©Çà(1¹Ú2ÀÏ Ã¼ÇèÇü)&rs ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
¡®¹ÔÀ¯¾îµå¸²¡¯ Âü¿© û¼Ò³â ¸ðÁý (2025-01-25)
ÇѽĿ¡ Àß ¾î¿ï¸®´Â ¿ÍÀÎ... 'Æ®¸®º¥Åä ÇÁ¶óÀ̺ø ¸®Àúºê ¸»º¤' (2025-01-25)
ÇÑÈ­½Ã½ºÅÛ, ±Û·Î¹ú ¼öÁØ ¹«ÀÎÇÔÁ¤ ±â¼ú ±¹³» ù È®º¸ (2025-01-25)
¿¡À̼­, ù Copilot+ PC ¡®½ºÀ§ÇÁÆ® °í AI¡¯ ½Ã¸®Áî ±¹³» Ãâ½Ã (2024-11-14)
¿£ÇÏÀÌÇ Á¦ÀÌ-Èñ½Â, Æ÷¸á¶óÅä ºÎÆ¼Å© ¿ÀÇ Çà»ç Âü¼® (2024-11-14)
Novotech Showcased in Global Biotech Series for Innovation i... (2025-06-19)
·Ôµ¥Ä«µå-¿ÀÄÉÀ̸ô, ¡®¿ÀÄÉÀ̸ôXµðÁö·ÎÄ«¡¯ Ä«µå Ãâ½Ã (2024-10-23)
¿ì¸®ÀºÇà, ³²¾çÁÖ¿¡ ¹Ì·¡Çü ÅëÇÕ IT¼¾ÅÍ °Ç¸³ ÃßÁø (2025-01-03)
Invivoscribe Announces Registration of the LeukoStrat¢ç CDx ... (2025-04-09)
°æÄÜÁø, ±¤±³ ¡®°æ±âXR¼¾ÅÍ¡¯ »ç¹«½Ç ÀÔÁÖÇÒ ÄÜÅÙÃ÷ ±â¾÷ ¸ðÁý (2024-10-27)
À×Ä«¿£Æ®¿÷½º, ±âÈÄ È¯°æ Ãë¾à °èÃþÀ» À§ÇØ ³ª´® ºÀ»ç (2025-01-30)
HistoSonics and Cambridge University Unveil Europe¡¯s First ... (2025-06-20)
MD ǰÆò»ó´ãȸ, â¾÷ÀÚÀÇ À¯Åë ÁøÀÔ ¸¶Áß¹° (2024-10-29)
On 3rd April 2025, MultiBank Group Delivered a Further Subst... (2025-04-11)
¿¹½º24, Çö´ë¾Æ¿ï·¿°ú Çù¾÷ÇØ ±âºÎ ¹ÙÀÚȸ (2024-10-06)
Çѱ¹, ·Îº¿ ¹Ðµµ ¼¼°è 1À§ (2024-11-22)
¼øÀÛ ¡®¾Æ¸óµå¡¤°ËÀºÄá À²¹«Â÷¡¯ ¹× ¡®ÅëÇö¹Ì °¡µæ ¹ã¡¤¸¶Â÷¡¯ ... (2024-10-07)
New Research from NetApp Finds One in Five Companies Unable ... (2024-12-16)
¡®»þ³Ú ¾Ú¹è¼­´õ¡¯ Á¦´Ï, ´õºíÀ¯ ÄÚ¸®¾Æ 11¿ù È£ Ä¿¹ö Àå½Ä (2024-10-31)
¡®µ¹½Ì ÇϿ콺¡¯ »õ·Î¿î ¡®Ç÷¯ÆÃ ÀåÀΡ¯ µî±Ø? ½ÉÄô ¸àÆ® ¿¬½Å ... (2024-10-31)
Àڻ쿹¹æ À§ÇÑ À߸øµÈ ÀÎ½Ä °³¼±... ¡®ÇÔ²²º¯È­ »ý¸íÀÇ ºû¡¯ Ä·... (2024-10-31)
½ÅÇÑÅõÀÚÁõ±Ç, »ý¼ºÇü AI ±â¹Ý ½ÃÀå Á¤º¸ Á¦°ø (2024-12-17)
Çѱ¹ ½ºÅ¸Æ®¾÷, ½Ç¸®Äܹ븮¿¡¼­ ¾ÆÅÂÁö¿ª Çõ½ÅÀÇ ¹Ì·¡ ¿­´Ù (2025-01-10)
±â¾Æ EV3, Ô¼ ¡®2024 °ñµç ½ºÆ¼¾î¸µ ÈÙ ¾î¿öµå¡¯ ¼ö»ó (2024-11-25)
¾ÆÄ«¶ó¶óÀÌÇÁ, Ȩ ¾ÛÀ¸·Î Å×½½¶ó Â÷·® Á¦¾î ±â´É Áö¿ø (2024-11-03)
       [ÀÌÀü][1]....[346][347][348][349][350][351][352][353][354]...[3698][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..